[{"address1": "100 Campus Drive", "address2": "Suite 102", "city": "Florham Park", "state": "NJ", "zip": "07932", "country": "United States", "phone": "877 742 8466", "website": "https://www.phathompharma.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.", "fullTimeEmployees": 452, "companyOfficers": [{"maxAge": 1, "name": "Ms. Terrie J. Curran", "age": 54, "title": "President, CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 1222527, "exercisedValue": 0, "unexercisedValue": 1865398}, {"maxAge": 1, "name": "Mr. David A. Socks", "age": 48, "title": "Co-Founder & Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 54167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Azmi  Nabulsi M.D., M.P.H.", "age": 63, "title": "Co-Founder & COO", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 888897, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Molly  Henderson CPA, MBA", "age": 52, "title": "Chief Financial & Business Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 777763, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Aditya  Kohli Ph.D.", "age": 35, "title": "Co-Founder", "yearBorn": 1988, "fiscalYear": 2023, "totalPay": 319647, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Cocja", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tom  Harris", "title": "Chief Development Sciences Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eckhard  Leifke M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin J. Gilligan", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 17.0, "open": 17.25, "dayLow": 16.95, "dayHigh": 18.58, "regularMarketPreviousClose": 17.0, "regularMarketOpen": 17.25, "regularMarketDayLow": 16.95, "regularMarketDayHigh": 18.58, "beta": 0.706, "forwardPE": -3.988889, "volume": 1254905, "regularMarketVolume": 1254905, "averageVolume": 751667, "averageVolume10days": 999770, "averageDailyVolume10Day": 999770, "bid": 17.9, "ask": 17.99, "bidSize": 200, "askSize": 200, "marketCap": 1225798400, "fiftyTwoWeekLow": 6.065, "fiftyTwoWeekHigh": 18.58, "priceToSalesTrailing12Months": 123.59331, "fiftyDayAverage": 12.1652, "twoHundredDayAverage": 9.889625, "currency": "USD", "enterpriseValue": 1243236224, "floatShares": 48399824, "sharesOutstanding": 68289600, "sharesShort": 14247663, "sharesShortPriorMonth": 13080324, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.2391, "heldPercentInsiders": 0.0883, "heldPercentInstitutions": 0.96436, "shortRatio": 17.33, "shortPercentOfFloat": 0.482, "bookValue": -3.99, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -297111008, "trailingEps": -5.18, "forwardEps": -4.5, "enterpriseToRevenue": 125.352, "enterpriseToEbitda": -4.932, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "PHAT", "underlyingSymbol": "PHAT", "shortName": "Phathom Pharmaceuticals, Inc.", "longName": "Phathom Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1572010200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "4c8c1fb1-8c10-35f8-ba4b-c2b6b83aa924", "gmtOffSetMilliseconds": -14400000, "currentPrice": 17.95, "targetHighPrice": 28.0, "targetLowPrice": 12.0, "targetMeanPrice": 22.57, "targetMedianPrice": 24.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 276236992, "totalCashPerShare": 4.635, "ebitda": -252071008, "totalDebt": 506376000, "quickRatio": 6.108, "currentRatio": 6.484, "totalRevenue": 9918000, "revenuePerShare": 0.172, "returnOnAssets": -0.54069, "freeCashflow": -154147008, "operatingCashflow": -215452000, "grossMargins": 0.80147004, "operatingMargins": -10.554339, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]